Y Griega CBD by Medical Seeds Co
Y Griega CBD by Medical Seeds Co. is a sativa-dominant strain developed to offer therapeutic benefits with minimal psychoactive effects. It emerged from a commitment to blend traditional sativa vigor with a balanced cannabinoid profile, responding to a growing consumer demand for medicinal cannabis options.
Appearance
Y Griega CBD exhibits a sativa-dominant plant structure, characterized by tall growth reaching 150-200 cm outdoors, with elongated, wispy leaves. The buds are dense and covered in trichomes, displaying colors that range from deep green to occasional purple hues, accented by amber pistils. This appearance is indicative of its quality and genetic heritage.
Cultivation studies note high trichome density, comparable to premium medicinal strains. The plant's structure promotes good light penetration and airflow, contributing to bud quality and potentially reducing mold issues.
Aroma & Flavor
The aroma of Y Griega CBD is a complex blend, featuring dominant herbal notes complemented by subtle citrus undertones. Sensory evaluations indicate a refreshing yet soothing olfactory profile, characteristic of its sativa lineage. The overall scent is invigorating and delicate.
Flavor profiles include citrus, earthy, floral, herbal, pine, pungent, spicy, and sweet notes. These contribute to a nuanced taste experience that is both complex and appealing to a wide range of users.
Effects
Users report that Y Griega CBD provides calm and energetic effects, making it suitable for daytime use. Preliminary studies indicated a significant improvement in relaxation scores among users, highlighting its therapeutic potential without intense psychoactivity.
The strain's balanced cannabinoid profile aims to deliver therapeutic benefits while minimizing the typical euphoria associated with high-THC cannabis, positioning it as a functional option for many.
Terpenes & Cannabinoids
Laboratory analyses have identified linalool and pinene as key terpenes contributing to Y Griega CBD's aroma and potential effects. Linalool adds floral and spicy notes, while pinene contributes a fresh, pine-like scent.
The strain is characterized by a CBD content typically ranging from 8% to 12%, with THC levels consistently below 0.3%. This specific cannabinoid ratio is a result of meticulous genetic selection and breeding over several years, meeting industrial hemp requirements in many regions.
Growing
Y Griega CBD demonstrates vigorous sativa growth, with plants reaching heights of 150-200 cm outdoors. Indoor cultivation requires training and pruning to manage its structure. It boasts a high germination success rate (95%) and consistent phenotypic expression (90%) under optimal conditions.
Yields in controlled indoor environments can exceed 500 grams per square meter. The plant's structure supports good airflow and light penetration, which are beneficial for bud development and plant health.
Origins & Lineage
Developed by Medical Seeds Co., Y Griega CBD is the result of over five years of meticulous breeding and selection, aiming to create a strain with therapeutic benefits and a balanced cannabinoid profile. It emerged in the early 2010s in response to consumer demand for medicinal cannabis options with reduced psychoactive effects.
Genomic analysis indicates approximately 70% sativa genetics, complemented by selected indica traits to enhance its therapeutic profile and temper sativa intensity. While specific parent strains are not detailed, its pedigree includes varieties known for medical efficacy and high CBD production.